Stocktoria
Assertio Holdings, Inc. ASRT
Nasdaq · stock · Pharmaceutical Preparations · website · IPO 1997-02-12
Assertio Holdings, Inc. financials (annual, from 10-K)
Bars are annual figures from 2019 to 2025; red bars are negative (a loss or cash outflow).
| Metric | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 | FY2019 |
|---|---|---|---|---|---|---|---|
| Revenue | $118.7M | $125.0M | $152.1M | $156.2M | $111.0M | $106.3M | $229.5M |
| R&D expense | $1.7M | $3.8M | $2.8M | $0 | — | — | — |
| SG&A expense | $69.0M | $75.1M | $78.6M | $46.8M | $52.6M | $104.3M | $108.9M |
| Operating income | -$21.5M | -$24.5M | -$243.5M | $39.4M | $9.4M | -$82.2M | -$194.4M |
| Interest expense | — | — | — | $8.0M | $10.2M | $15.9M | $58.4M |
| Income tax | $435,000 | $52,000 | $77.9M | -$78.5M | $728,000 | -$17.4M | -$5.3M |
| Net income | -$30.4M | -$21.6M | -$331.9M | $109.6M | -$1.3M | -$28.1M | -$217.2M |
| EPS (diluted) | $-4.74 | $-3.40 | $-4.67 | $2.03 | $-0.03 | $-1.07 | $-3.07 |
| Operating cash flow | -$28.2M | $26.4M | $49.6M | $78.6M | $5.5M | -$65.6M | $90.5M |
| Free cash flow | — | $26.4M | $49.0M | $78.3M | $5.5M | -$65.6M | $89.0M |
| Cash & equivalents | $10.2M | $50.6M | $73.4M | $64.9M | $36.8M | $20.8M | $42.1M |
| Inventory | $24.1M | $38.3M | $37.7M | $13.7M | $7.5M | $11.7M | $3.4M |
| Total assets | $267.0M | $284.7M | $286.4M | $413.9M | $326.5M | $303.3M | $527.2M |
| Total liabilities | $173.0M | $163.7M | $148.4M | $188.2M | $224.1M | $247.8M | $469.2M |
| Shareholders' equity | $94.0M | $121.1M | $138.0M | $225.7M | $102.4M | $55.5M | $58.0M |
Growth · year-over-year · Revenue CAGR -10.4%
| Metric | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 | FY2019 |
|---|---|---|---|---|---|---|---|
| Revenue growth | -5.0% | -17.8% | -2.7% | +40.7% | +4.5% | -53.7% | — |
| Net income growth | — | — | -402.8% | — | — | — | — |
| EPS growth | — | — | -330.0% | — | — | — | — |
| Free cash flow growth | — | -46.1% | -37.5% | +1331.9% | — | -173.7% | — |
Each column is the change versus the prior fiscal year. Growth off a negative or zero base is shown as “—”. CAGR is the compound annual revenue growth across the years shown.
Source: SEC EDGAR filings · CIK 0001808665 · US · as of 2025-12-31. facts plus Stocktoria's own computed scores — not investment advice.